Learn more

ADVANCED VIRAL RES CORP

Overview
  • Total Patents
    70
About

ADVANCED VIRAL RES CORP has a total of 70 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are TRIFOILIUM APS, POPULATION COUNCIL INC and YUYU PHARMA INC.

Patent filings per year

Chart showing ADVANCED VIRAL RES CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Hirschman Shalom Z 56
#2 Friedland Bernard 14
#3 Taraporewala Irach B 6
#4 Wilner Eli 4
#5 Cohen Mathew 3
#6 Huang Wenlin 2
#7 Bregman William 1
#8 Taraporewala I B 1
#9 Hirschman Shalon Z 1
#10 Hirschman S Z 1

Latest patents

Publication Filing date Title
CA2578212A1 Methods for promoting wound healing
WO2006091222A2 Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118
US2005180966A1 Method for treating autoimmune diseases
WO2005079269A2 Method of treating carcinomas
US7439234B2 Method for treating cancer patients undergoing chemotherapy
US2004033244A1 Treatment of cancers of lymphocytic cells with product R
IL147496A Preparation of a therapeutic composition
AU8895701A Inhibition of adenovirus replication by product r, a peptide nucleic acid immunomodulator
US2002004579A1 Preparation of a therapeutic composition
US6303153B1 Preparation of a therapeutic composition
US7067139B2 Method for treating autoimmune diseases
EP0988042A1 Combination of product r and an antiviral agent in the therapy of hiv infections
BR9808873A Method for treating papillomavirus infection
WO9846240A1 Topical treatment of skin diseases and eye afflictions
CA2501751A1 A combination therapy for hiv infections
US5807840A Method for treating canine distemper
US5807839A Method for stimulating red blood cell production
US5902786A Treatment of basal cell carcinoma with product R, a peptide-nucleic acid preparation
US6268349B1 Method for treating B19 parvovirus infections